Connect your AI

TTRX TTRX Contingent Consideration Classified As Equity Fair Value Disclosure

Contingent Consideration Classified As Equity Fair Value Disclosure at other companies

CareCloud, Inc.CCLD

$1.13M+960%

StereotaxisSTXS

$1.08M—

Community Financial SystemCBU

$225K-89.3%

LifeStance Health GroupLFST

-$1.01M—

Tetra TechTTEK

$58K-97.0%

Pacira BioSciences, Inc.PCRX

$15.79M-10.1%

Other financials

Income statement

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

Operating cash flow-$1.6M-448%

Valuation

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's contingent consideration classified as equity fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is TTRX's contingent consideration classified as equity fair value disclosure?: TTRX (TTRX) reported contingent consideration classified as equity fair value disclosure of 20,000,000% in Q1 2026.